← Live StudiesRegistry: recruitingPhase 2

Macupatide and eloralintide for weight management

Compares investigational macupatide and eloralintide, alone or together, with placebo for weight loss in adults with obesity or overweight who do not have type 2 diabetes. Part of a Lilly master protocol (NCT06143956).

Ask about this study Refer a patient View official study record

Who it's for

Ages 18–75
No type 1 or type 2 diabetes
Additional master protocol criteria

Full eligibility rules apply. The study team decides who can take part.

Where it runs

7 research locations in Arizona and California.

Arizona

Arizona Clinical Trials - MesaChandler, AZ
Headlands Research - ScottsdaleScottsdale, AZ
Arizona Liver Health - TucsonTucson, AZ

California

NorCal Medical Research, IncGreenbrae, CA
Velocity Clinical Research, Huntington ParkHuntington Park, CA
Peninsula Research AssociatesRolling Hills Estates, CA
Diablo Clinical Research, Inc.Walnut Creek, CA

Site recruitment may change. The official record lists every location, including outside these states.

Interested in this study?

Ask us about it, or refer a patient. Taking part is voluntary, and the study team decides who can join.

Ask about this study Refer a patient

Important information about clinical research

InvestigatorX is an independent information directory. Being listed here does not mean a sponsor, research institution or investigator is affiliated with InvestigatorX. ClinicalTrials.gov registration is not FDA approval of a study drug, an endorsement, or confirmation that a particular site is currently accepting participants.

Summaries are informational and do not determine clinical eligibility. Research can involve risks, including investigational medications and placebo assignment. Always review the ClinicalTrials.gov study basics and speak with a qualified healthcare professional and the authorized study team.

No medical information is collected on this page. For accurate criteria, contacts, and the latest recruitment status, select View official study record on each study's page.

Research listings compiled October 20, 2026. Source: U.S. ClinicalTrials.gov and registry-indexed study information. Independent site; not a U.S. government service. Study data can change without notice.